| Pharmaceutical active ingredients: |
| Ethinyl EstradiolNorethindrone |
| Available forms, composition and doses of Sinovula: |
| N / A |
| Sinovula medical category: |
| Human:Oral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA05 - Norethisterone and estrogenG03AB04 - Norethisterone and estrogenG03CA01 - Ethinylestradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Chiesi |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Palonyl | Ethinyl Estradiol; Norethindrone | Unidentified Pharmaceutical Company |
| Perovex | Ethinyl Estradiol; Norethindrone | Unidentified Pharmaceutical Company |
| Select 1 / 35 | Ethinyl Estradiol; Norethindrone | Pfizer |
| Select 1 / 35 21-Day | Ethinyl Estradiol; Norethindrone | Pfizer |
| Select 1 / 35 28-Day | Ethinyl Estradiol; Norethindrone | Pfizer |
| Synfase | Ethinyl Estradiol; Norethindrone | Pfizer |
| Synphase | Ethinyl Estradiol; Norethindrone | Pfizer |
| Synphasec | Ethinyl Estradiol; Norethindrone | Grunenthal |
| Synphasic | Ethinyl Estradiol; Norethindrone | Pfizer; Syntex |
| Synphasic 21 | Ethinyl Estradiol; Norethindrone | Pfizer; Syntex |